Abbott Diagnostics Technologies AS
Score · fiscal year 2025
45of 100
How to read this: the company is ahead of 39 % of companies in the Morning class Large in the same sector in 2025. What does this mean?
Rank in the Morning class Large: 190 of 312 · What are Morning company classes?
Place in the whole sector: 1,476 of 2,392 · Industri
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 61 and solidity 71 out of 100 among companies in the Morning class Large in the same sector in 2025. Methodology
Against the sector
Abbott Diagnostics Technologies AS is 4 points below the median for companies in the Morning class Large in the same sector in 2025.
Median score 49 among 312 companies.
Against companies in the Morning class Large in the same sector in 2025: operating margin 8.3% (median 6.3%) and equity ratio 50.3% (median 33.3%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 1,734 MNOK | 1,147 MNOK |
| Operating margin | 8.3% | 6.3% |
| Profit margin | 8.7% | 6.5% |
| Return on assets | 14.2% | 11.5% |
| Equity ratio | 50.3% | 33.3% |
| Debt-to-equity | 0.99 | 1.94 |
| Current ratio | 1.00 | 1.31 |
| Revenue growth | −12.7% | 7.2% |
| Revenue per employee | 6.22 MNOK | 6.01 MNOK |
The median and “ahead of” refer to companies in the Morning class Large in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 45, Abbott Diagnostics Technologies AS does better than 39% of companies in the Morning class Large in the same sector (312 companies) in 2025.
Score 2023–2025
- Abbott Diagnostics Technologies AS
- Median: companies in the Morning class Large in the same sector
Abbott Diagnostics Technologies AS has a score of 45 for 2025, rank 1,476 of 2,392 in the sector.
Strongest: Solidity: percentile 71 against peers, equity ratio 50.3% against a median of 33.3%. Profitability: percentile 61 against peers, operating margin 8.3% against a median of 6.3%.
Weakest: Growth: percentile 6 against peers, revenue growth −12.7% against a median of 7.2%. Liquidity: percentile 23 against peers, current ratio 1.00 against a median of 1.31.
Worth a closer look
- Consider strengthening liquidity: current liabilities are 1.0 times current assets. Based on: current ratio 1.00 (median 1.31).
- What lies behind weak growth, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
Abbott Diagnostics Technologies AS had an operating margin of 8.3% and an equity ratio of 50.3% in 2025, and ranks 1,476 of 2,392 in Industri.
From 2024 to 2025: the operating margin fell from 21.9% to 8.3% and the equity ratio fell from 60.6% to 50.3%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 644 MNOK and 1,189 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 1,189 MNOK |
| EV/EBIT | 8.0 | 1,170 MNOK |
| P/B | 1.0 | 644 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
Consider strengthening liquidity: current liabilities are 1.0 times current assets.
Based on: Current ratio 1.00 (median 1.31).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 4.7% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of −0.8%. Based on the 10 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 61 | weight 30% |
|---|---|---|
| Solidity | 71 | weight 25% |
| Liquidity | 23 | weight 15% |
| Growth | 6 | weight 15% |
| Consistency | 29 | weight 15% |
Durability: 57 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is Abbott Diagnostics Technologies AS?
The operating margin was 8.3% in 2025, against a median of 6.3% among companies in the Morning class Large in the same sector. Return on assets was 14.2%.
How solid is Abbott Diagnostics Technologies AS?
The equity ratio was 50.3% in 2025 (median 33.3%). Debt-to-equity was 0.99 (median 1.94).
What is the liquidity of Abbott Diagnostics Technologies AS like?
The current ratio was 1.00 in 2025 (median 1.31). Current assets did not cover current liabilities.
How does Abbott Diagnostics Technologies AS compare in Industri?
Abbott Diagnostics Technologies AS ranks 1,476 of 2,392 in Industri for 2025. Among companies in the Morning class Large it is number 190 of 312. Revenue changed by −12.7% from the year before.
From the Central Coordinating Register
- Org. no.
- 981363019
- Legal form
- AS
- Sector
- Industri (21.200)
- Morning company class
- Large
- Employees
- 279 registered 10 October 2026
- Founded
- 6 December 1999 26 years in operation
- Share capital
- 2.00 MNOK
- Business address
- Kjelsåsveien 161, 0884 OSLO
- Municipality
- Oslo rank 63–220 of 357 in Norway
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 31 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 31 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 52 | 74 | 45 | |
| Rank | 1,084 | 202 | 1,476 | |
| Operating margin | −0.5% | 21.9% | 8.3% | |
| Return on assets | 8.0% | 38.6% | 14.2% | |
| Equity ratio | 79.2% | 60.6% | 50.3% | |
| Current ratio | 1.47 | 1.08 | 1.00 | |
| Revenue growth | – | 43.9% | −12.7% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 1,380.1 MNOK | 1,985.8 MNOK | 1,734.1 MNOK |
| Operating profit | −6.5 MNOK | 435.4 MNOK | 144.7 MNOK |
| Profit before tax | 78.8 MNOK | 489.9 MNOK | 151.6 MNOK |
| Net profit | 62.3 MNOK | 382.4 MNOK | 118.9 MNOK |
| Financial expenses | 48.4 MNOK | 33.8 MNOK | 29.7 MNOK |
| Total assets | 1,596.1 MNOK | 1,357.3 MNOK | 1,281.3 MNOK |
| Current assets | 487.1 MNOK | 579.1 MNOK | 635.5 MNOK |
| Equity | 1,264.9 MNOK | 822.3 MNOK | 644.2 MNOK |
| Retained earnings | 62.3 MNOK | 382.4 MNOK | 204.3 MNOK |
| Total liabilities | 331.2 MNOK | 535.0 MNOK | 637.2 MNOK |
| Current liabilities | 331.2 MNOK | 535.0 MNOK | 637.2 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 31 October 2026, accounts id 7033972.
Further
Similar companies
- Elkem ASA index 45, rank 1,460 · compare
- KONGSBERG DEFENCE & Aerospace AS index 45, rank 1,463 · compare
- Schindler AS index 45, rank 1,464 · compare
- Autronica Fire and Security AS index 45, rank 1,489 · compare
- Heras Norway AS index 44, rank 1,496 · compare